Evolus
EOLS | NASDAQ
$6.63
-$0.33 (-4.74%)
At close: Nov 16, 2026, 4:00 PM ET
$6.63
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-4.74%
(1D)No price chart data available for 1D timeframe.
Rating
53.2
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #212/1021 (Top 21%)
Key Statistics
Market Data
Market Cap $438.83M
1D Range
6.61 7.03
52W Range
3.94 9.30
Valuation (TTM)
PE -14.11
PB -11.60
EV/EBITDA -127.22
Valuation (NTM)
Forward PE 22.64
Forward PEG 0.16
Price Target $15.00
Cash Flow
FCF Yield -1.3%
SBC Adj. FCF Yield -6.2%
SBC Impact -384.0%
Margins
Gross Margin 65.9%
Operating Margin -5.7%
FCF Margin -1.7%
Growth (CAGR)
Revenue 3Y | 5Y 20.8% |
30.6%
Dil EPS 3Y | 5Y 28.7% |
21.6%
FCF 3Y | 5Y 34.0% |
34.0%
Returns
ROA -11.0%
ROE 103.2%
ROIC -12.8%
Financial Health
Net Debt
$115.2M
Current Ratio 1.42
Interest Coverage -1.13
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio...
Sector Healthcare
Employees 353
IPO Date Feb 8, 2018
Website www.evolus.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 4, 2026
EPS
-$0.09
Miss -45.16%
YoY:
+35.71% REV
$78M
Beat +0.54%
YoY:
+13.10%Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
5
Consensus
Buy
Price Target
$15.00
Upside
+126.24%
Buy (4)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove EOLS